Sign in

Dan Routledge

@droutledge.bsky.social
430 followers 193 following 18 posts

Front Section Senior Editor for PLOS Medicine - Views are my own

PostsRepliesMedia
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 22/09/2026
🚨 Conference attendance! Front Section Senior Editor Daniel Routledge @droutledge.bsky.social will be at the World Cancer Congress in Hong Kong this week! If you're also attending and want to discuss your research, the journal, open science, or more, feel free to reach out or say hi!🧪 #WCC2026
043
Dan Routledge @droutledge.bsky.social · 21/09/2026
I first heard Gemma and Jodie present at the @crick.ac.uk Rare Diseases conference earlier this year, and it was a pleasure working with them on this Perspective article that emphasises a valuable message: that lived experience can and does meaningfully inform (rare disease) research🧪👏
021
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 24/07/2026
Responses to viral outbreaks have changed. In this Editorial, Rebecca Grais outlines how #COVID-19 transformed #outbreak responses from a predominantly public health challenge to a political & security concern, highlighting challenges of managing competing fears and risks🧪 #MedSky plos.io/4fRycuP
plos.io
Whose fears count? Legitimacy, trust and viral outbreak responses after COVID-19
In this Editorial, Rebecca Grais outlines how COVID-19 transformed viral outbreak responses from a predominantly public health challenge into a political and security concern, highlighting the challen...
023
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 21/07/2026
Chimeric antigen receptor (CAR)-expressing cells show great potential for the treatment of #autoimmune diseases (AID). In this Perspective, Jule Bachl, Melanie Hagen & Georg Schett discuss challenges & potential of recent CAR-T developments in transforming care for patients with AID🧪 plos.io/4ywwBlt
plos.io
Progress and promise of CAR-T cell treatment in autoimmune diseases
Chimeric antigen receptor (CAR)-expressing cells bear a great potential for the treatment of autoimmune diseases. In this Perspective, Jule Bachl, Melanie Hagen, and George Schett discuss the challeng...
032
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 17/07/2026
#Measles and other #vaccine -preventable diseases are re-emerging worldwide. In this Perspective, Chirag Kumar & Nathan Lo (@nathanlo.bsky.social) outline how targeted policy interventions in locations at greatest risk may be an effective strategy to curb this public health threat🧪💉 plos.io/4vUmchb
plos.io
Re-emergence of vaccine-preventable diseases in the post-elimination era
Measles and other vaccine-preventable diseases are re-emerging worldwide in locations where they were once eliminated. In this Perspective, Chirag Kumar and Nathan Lo outline how and why targeted poli...
054
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 06/07/2026
Despite public health strategies focusing on men’s #mentalhealth and #suicide risk, suicide rates among men remain high. In this Editorial, Seena Fazel outlines why targeted approaches for high-risk individuals should be prioritized alongside broader population-level strategies🧪 plos.io/3TkI9Ij
plos.io
Improving suicide prevention in men
Despite public health strategies focusing on men’s mental health and suicide risk, rates of suicide among men remain concerningly high. In this Editorial, Seena Fazel outlines why targeted, specialize...
021
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 02/06/2026
In this Perspective, Caitlin Ryus and colleagues discuss the #NIH 2025 Public Access Policy, highlighting that while expanding who can read science, the policy risks creating new barriers to who can afford to perform and publish their science 🧪 #MedSky #openscience #openaccess plos.io/4fVTyri
plos.io
The NIH 2025 Public Access Policy: Immediate access, unequal costs
In this Perspective, Caitlin Ryus and colleagues discuss the NIH 2025 Public Access Policy, highlighting that while expanding who can read science, the policy risks creating new barriers to who can af...
043
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 22/05/2026
Suppression of HIV with antiretrovirals eliminates HIV transmission risk: Undetectable = Untransmittable (U=U). In this Perspective, Thiago Torres & Paula Luz outline what is needed to improve equity and accuracy in global awareness and education of U=U to reduce stigma. 🧪 #MedSky bit.ly/42OXQcs
bit.ly
U = U for all: Advancing equity in HIV prevention
Suppression of HIV with antiretrovirals eliminates HIV transmission risk, summarized as Undetectable = Untransmittable (U=U). However, U=U literacy remains unevenly understood and shared, and stigmas ...
062
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 20/05/2026
📸Some of our editors enjoying the #MSFSciDays conference in London! Please do come along to the @plos.org stand and say hello if you are attending!
043
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 12/05/2026
In this Perspective, Silja Kosola outlines how social media disproportionately harms youth #mentalhealth, arguing that recent policy changes aimed at protecting youth are welcome, but stricter age limits & greater accountability of #socialmedia companies are needed🧪🧠🤳 #MedSky plos.io/4tBacjj
plos.io
Connected or chained by social media? Child and adolescent mental health in a digital era
In this Perspective, Silja Kosola outlines how social media disproportionately harms child and adolescent mental health, and argues that while recent policy changes aimed at protecting youth from soci...
031
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 11/05/2026
In this Perspective, Sanjay Rajagopalan and colleagues discuss how #climatechange accelerates non-communicable diseases (NCDs) and exacerbates NCD-related mortality, calling for greater visibility and funding to address this syndemic 🧪🌍 #MedSky #climate #health plos.io/3RxvUqV
plos.io
Climate change and non-communicable diseases: An invisible syndemic
In this Perspective, Sanjay Rajagopalan and colleagues discusses how climate change accelerates non-communicable diseases (NCDs) and exacerbates NCD-related mortality, and calls for greater visibility...
061
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 29/04/2026
Why #obesity increases #cancer risk has long remained a biological mystery. In this Perspective, Steven Moore & Patrick Ryan discuss rapid advances in statistical & analytical methods that are opening the door to mechanistic discoveries that may help resolve this question🧪 #MedSky plos.io/4umSMb3
plos.io
Obesity and cancer: Methodological frontiers for mechanistic discoveries
Why obesity increases cancer risk has long remained a biological mystery. In this Perspective, Steven Moore and Patrick Ryan discuss rapid advances in statistical and analytical methods that are now o...
042
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 24/04/2026
It's #WorldImmunizationWeek 💉this year's theme is "for every generation, vaccines work". This week we are amplifying this message by highlighting research & perspectives evaluating & demonstrating the efficacy, safety, cost-effectiveness & impact of #vaccines in protecting health & saving lives🧪
0136
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 10/04/2026
Integrating spatial #omics with #AI is likely to advance biomarker research & diagnostics. In this Editorial, Academic Editor Nic Reitsam discusses the potential & challenges of utilizing AI in the development of scalable & reproducible quantification in routine #cancer pathology 🧪
plos.io
Spatial omics and AI for clinically actionable cancer biomarkers
In this Editorial, Nic Reitsam discusses how integrating spatial omics with artificial intelligence is likely to advance biomarker research and diagnostics, including the potentials and challenges of…
021
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 07/04/2026
(1) The future of medicine in a One Health world plos.io/3OsNI5v (2) Living to our full potential: Reassessing global sex inequalities in life expectancy plos.io/41fm8vt (3)From crisis response to country control: Restoring agency and sustainability in global health plos.io/41jaP5w #WorldHealthDay🌍
041
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 07/04/2026
In recognition of @who.int #WorldHealthDay 🌍, below we highlight three recent Perspectives discussing pressing challenges within #OneHealth, #globalhealth & #publichealth, exemplifying the need for innovative, international & interdisciplinary approaches to improving health around the world🧪 #MedSky
164
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 02/04/2026
In this Perspective, Amanda Drury and colleagues outline how and why education, communication, and models of care for patients receiving oral systemic anti-cancer therapies must adapt to support safe, equitable, and sustainable treatment 🧪 #cancer #MedSky
plos.io
Supporting patients receiving oral systemic anti-cancer therapies
In this Perspective, Amanda Drury and colleagues outline how and why education, communication, and models of care for patients receiving oral systemic anti-cancer therapies must adapt to support…
051
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 03/03/2026
March is #Endometriosis Awareness Month, and this Editorial by Alex Tosun (@atosun.bsky.social) discusses why greater awareness, education, funding and research for this systemic condition is imperative to redefining pain, equity, and investment in women’s health 🧪🌻 #Medsky plos.io/4slvscE
plos.io
From pain to policy: Improving endometriosis awareness, diagnosis, and treatment
In recognition of Endometriosis Awareness Month, this Editorial by Alexandra Tosun discusses why raising awareness and education of endometriosis, as well as increasing funding and research for this s...
02423
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 28/02/2026
In recognition of Rare Disease Day, this Perspective by Tudor Groza & co discusses how AI can transform rare disease care when organized around patients, outlining a patient-clinician-AI triad spanning diagnosis, clinical trials, & individualized therapies🧪 #RareDiseaseDay
plos.io
Reimagining care of people living with rare diseases with artificial intelligence
In this Perspective, Tudor Groza and colleagues discuss how artificial intelligence (AI) can transform rare disease care when organized around the patient journey, outlining a patient-clinician-AI…
0127
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 11/02/2026
In recognition of International Day of Women and Girls in STEM, this Editorial by Aparajita Chattopadhyay reflects on the gender gap in #STEM in India, outlining socio-cultural & infrastructural factors, recent promising trends, and what is needed to continue these transformations 🧪
plos.io
Let her shine: Empowering women and closing India’s gender gap in STEM
In recognition of International day of women and girls in STEM, this Editorial by Aparajita Chattopadhyay reflects on the gender gap in STEM in India, outlining socio-cultural and infrastructural…
073
Reposted by Dan Routledge
PLOS Biology @plosbiology.org · 03/02/2026
PLOS Biology is proud to present our new collection of comment and opinionated review articles on the many facets of #immunometabolism! 🧪 #immunosky #immunology #metabolism plos.io/4c5z6Cn See 🧵⬇️ for more details
plos.io
The many facets of immunometabolism
This Collection of articles aims to shine a light on the many facets of immunometabolism, highlighting how molecular and cellular mechanisms impact diverse tissue and organismal functions and the exci...
11612
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 30/01/2026
In this Editorial, PLOS Medicine Editor-in-Chief Till Bärnighausen and Executive Editor Helen Lumbard outline how #climate change and associated extreme weather events are threatening human health, and call for research on the effectiveness of climate adaptation interventions🧪🌍 plos.io/4adxog2
plos.io
Intervention research to protect human health in the era of climate extremes
In this Editorial, PLOS Medicine Editor-in-Chief Till Bärnighausen and Executive Editor Helen Lumbard outline how climate change and associated extreme weather events are threatening human health, and...
063
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 16/01/2026
GLP-1-based medications for obesity have seen unprecedented rises in popularity. However, as outlined by Ariana Chao & co in this Perspective, this rapid growth is met with rising concerns about side effects, long-term outcomes & predatory marketing practices🧪 #GLP-1 #obesity #Medsky plos.io/4qAXy2U
plos.io
Glucagon-like peptide-1 receptor agonists for obesity: Growing popularity met with growing questions over safety
In this Perspective, Ariana Chao, Adam Gilden and Thomas Wadden discuss why alongside the rising popularity of glucagon-like peptide 1 (GLP-1)-based medications for obesity, there are also concerns ab...
071
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 14/01/2026
Next in our 'meet the editors' is Front Section Senior Editor, Dan Routledge (@droutledge.bsky.social). Dan leads the journal's "magazine" section, handling articles offering perspectives, critiques & guidance for our broad readership of clinicians, researchers, health workers, policymakers & more 🧪
061
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 18/12/2025
Open research & data transparency protect against unethical activities, but can also introduce integrity risks. In this Perspective, @dmaupin.bsky.social, Matt Spick & Nophar Geifman set out the case for the use of safeguarding practices to protect against data exploitation🧪 #MedSky
plos.io
Safeguarding Open Science from exploitative practices
Open research and data transparency are a bulwark against unethical activities, but can also introduce integrity risks. In this Perspective, Danny Maupin, Matt Spick and Nophar Geifman argue that…
042
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 17/12/2025
Controlling transmission of bacterial #STIs has proven difficult in recent years. In this Perspective, Sami Gottlieb & colleagues highlight the need for innovative research, expedited clinical development & increased investment in the development of #vaccines against bacterial STIs🧪🦠 plos.io/4j7PpjU
plos.io
Vaccines to prevent bacterial sexually transmitted infections: Promise, progress, and public health potential
Controlling transmission of the bacterial sexually transmitted infections (STIs) gonorrhoea, chlamydia and syphilis has proven difficult in recent years, and new solutions are needed. In this Perspect...
021
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 10/12/2025
Analyses of open health datasets can offer valuable contributions to health & medicine, but recent years have seen a proliferation of papers lacking robust or novel findings. In this Editorial, we provide guidance for conducting & reporting high-quality analyses using open datasets🧪 plos.io/4poBmZo
plos.io
Setting the standard for high-quality studies using open health datasets
Large open health datasets present unique opportunities for studies that when well-designed, conducted, and reported, can offer valuable contributions to health and medicine. However, recent years hav...
1139
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 03/12/2025
Did you know that you may be eligible to publish in PLOS Medicine without paying an APC? All PLOS journals offer several APC-alternative business agreements through institutional partnerships.📝🧪 To learn more and find out if your institution has an agreement, visit: plos.org/libraries/pa...
plos.org
Institutional Partners - PLOS
Institutional partners Open access is not truly open without equitable opportunities to publish. To support authors from diverse research communities, funding backgrounds…
042
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 01/12/2025
In recognition of World AIDS Day 2025, this Perspective by Gregory Folkers & Anthony Fauci reflects on progress made in #antiretroviral treatments & prevention of HIV/AIDS, highlighting promising therapeutic developments and looking ahead to what is needed to end the #AIDS epidemic 🧪 plos.io/48np3Fu
plos.io
Treatment and prevention of HIV/AIDS: Unfinished business
In recognition of World AIDS Day 2025, this Perspective by Gregory Folkers and Anthony Fauci reflects on the progress made in antiretroviral treatments and prevention of HIV/AIDS, highlighting promisi...
1148
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 28/11/2025
We are pleased to sponsor the online seminar, "Global Health After the Breakpoint: Evidence for What Comes Next", featuring a panel of experts to discuss the future of global health. It's not too late to register using the link below! 🧪 📆 Tuesday 2nd Dec 🕐3.00-4.30pm GMT duke.zoom.us/webinar/regi...
143
Reposted by Dan Routledge
PLOS Medicine @plosmedicine.org · 21/11/2025
We pride ourselves on our commitments to open science, integrity, and equity in research. If you want to learn more, this Editorial by Executive Editor Helen Lumbard & Editor-in-Chief Till Bärnighausen outlines our scope and vision, and reaffirms our drive for meaningful change 🧪 plos.io/3XFZfzg
plos.io
Charting the future of PLOS Medicine: Priorities for evidence, impact, and equity
As PLOS Medicine enters a new chapter, its leadership sets out a bold editorial vision grounded in evidence, impact and equity. In a rapidly evolving global health landscape, the journal reaffirms its...
044
Dan Routledge @droutledge.bsky.social · 20/11/2025
PLOS Medicine is now on Bluesky! 🦋 Go and give us a follow 😀⬇️ #MedSky #PLOS
010
Reposted by Dan Routledge
Florian Naudet @floriannaudet.bsky.social · 16/10/2025
😃 to share this new @plos.org Medicine 📄 written in collaboration with the super cool @kahin-tai.bsky.social (from the super cool @sharectd.bsky.social doctoral network), Gérard Legoff, @annelelouarn.bsky.social & @synthymama.bsky.social.
journals.plos.org
Open science must include effective results dissemination to study participants
Open science often centers around publications and data transparency. This Perspective discusses how and why disseminating results to study participants is essential for maximizing the values and bene...
2127
Reposted by Dan Routledge
Elisabeth Bik @elisabethbik.bsky.social · 06/10/2025
The 2025 #NobelPrize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance.”
Cartoon from the Nobel Assembly showing the three prize winners, their names, and “for their discoveries concerning peripheral immune tolerance.”
010020
Dan Routledge @droutledge.bsky.social · 06/10/2025
In our latest Editorial, PLOS Medicine Executive Editor Helen Lumbard and I call for the scientific community to tackle research fraud and paper mills head on by creating robust systems of data sharing and transparency 🧪 #PLOSMedicine #datasharing #openscience @plos.org 📄➡️ plos.io/4nDKQ2c
journals.plos.org
Open science and transparency are our strongest tools in the fight against fraudulent publishing activities
PLOS Medicine Executive Editor, Helen Lumbard, and Senior Editor, Front Section, Daniel Routledge, call for the scientific community to tackle research fraud and paper mills head on by creating robust...
025
Reposted by Dan Routledge
PLOS Biology @plosbiology.org · 14/08/2025
We are proud to announce a new agreement with @rorinstitute.bsky.social and @aimosinc.bsky.social to become a partner journal with MetaResearch Open Review (MetaRoR) @metaror.bsky.social #metaresearch #openscience 🧪 Learn more: plos.io/45wPZB9
plos.io
PLOS Biology announces agreement to become a MetaROR partner journal - The Official PLOS Blog
Note: PLOS issued the following press release on Thursday, August 14th. SAN FRANCISCO, CA — Today, PLOS Biology announced a new agreement…
1207
Reposted by Dan Routledge
PLOS @plos.org · 15/08/2025
Charting the future of PLOS Medicine – in their Editorial, Executive Editor, Helen Lumbard, and Editor-in-Chief, Till Baernighausen, outline their vision for the journal’s next chapter and reaffirm its commitment to diversity, openness, and actionable science. 🧪 ➡️ plos.io/41mvhTx
plos.io
Charting the future of PLOS Medicine: Priorities for evidence, impact, and equity
As PLOS Medicine enters a new chapter, its leadership sets out a bold editorial vision grounded in evidence, impact and equity. In a rapidly evolving global health landscape, the journal reaffirms its...
065
Reposted by Dan Routledge
PLOS Biology @plosbiology.org · 01/08/2025
Our new Collection on #cancer is out now! We delve into how #omics technologies are helping researchers to better understand what goes on in the tumor microenvironment 🧪 See 🧵⬇️ for more info on the articles 1/9 plos.io/4mgHDEw
plos.io
Unveiling cancer crosstalk across spatial and temporal scales
This collection focuses on how recent technological advancements in omics approaches (genomics, proteomics, metabolomics etc.) have enhanced our understanding of the mechanisms governing tumor progres...
1126
Reposted by Dan Routledge
PLOS Biology @plosbiology.org · 12/06/2025
What links #migraine aura and #headache? In this Essay, Anders Hougaard, Messoud Ashina &co delve into the mechanistic and pathophysiological relationship between migraine aura and headache. 🧪 plos.io/3HUaY8I
plos.io
The mysterious link between migraine aura and migraine headache
The relationship between migraine aura and headache has been the subject of a long-standing debate. With insights from clinical, pharmaceutical, and in vivo animal studies, this Essay delves into the ...
1278
Dan Routledge @droutledge.bsky.social · 25/04/2025
It was so nice to visit my old stomping ground in Exeter visiting the @lsiexeter.bsky.social and to give a talk about working in publishing and being an editor at @plos.org as part of the LSI Career Day 📖 And great to see some old colleagues and my PhD supervisor @scholpplab.bsky.social again!
020
Reposted by Dan Routledge
PLOS Biology @plosbiology.org · 24/04/2025
Our latest editorial in defense of #vaccines and vaccination introduces two Perspectives on priorities for outbreak vaccination, as well as the important successes of vaccines to date ⬇️ plos.io/4lKHvxy plos.io/4lLQqio plos.io/3RSlwr3 Please read and spread the word this #WorldImmunizationWeek 💉
plos.io
Vaccines work… and do not cause autism
Vaccines have saved millions of lives, yet their importance and safety is repeatedly in question. W e cannot let disinformation campaigns get in the way of global public health – it is not time to def...
073
Reposted by Dan Routledge
Alex Eve @amjeve.uk · 23/04/2025
#DevBio job opportunity! Development (@dev-journal.bsky.social) is looking for a new Community Manager to run our community site, the Node (@the-node.bsky.social) – a great opportunity if you love devbio, #stemcells, #scicom and community engagement. Happy to chat informally about the role. ⬇️
biologists.com
Work for us
Working for us We’re always looking for talented and motivated people to work as part of our close-knit team. Roles range from editorial to production, marketing to event co-ordination, HR to accounts...
0916
Reposted by Dan Routledge
Nonia Pariente @npariente.bsky.social · 20/04/2025
Vacciness have saved > 6 lives/min in the last 50 years, yet their importance & safety is often questioned “We should not allow misinformation, disinformation, ignorance and defunding to hinder vaccine development, deployment and use” My latest @plosbiology.org journals.plos.org/plosbiology/...
journals.plos.org
Vaccines work… and do not cause autism
Vaccines have saved millions of lives, yet their importance and safety is repeatedly in question. W e cannot let disinformation campaigns get in the way of global public health – it is not time to def...
16533
Reposted by Dan Routledge
PLOS Biology @plosbiology.org · 20/04/2025
Our latest editorial in defense of vaccines and vaccination, introduces two Perspectives in this issue on priorities for outbreak vaccination, as well as the important successes of vaccines to date Please read and spread the word 🙏🏻!
15539
Reposted by Dan Routledge
PLOS Biology @plosbiology.org · 16/04/2025
How did #vocal communication come to dominate human #language? This Unsolved Mystery discusses evidence suggesting that fetal auditory development & learning in the womb are important factors that contributed to human language evolving via a vocal, rather than gestural, route 🗣️🧪 ▶️ plos.io/3EjnKMT
1143
Reposted by Dan Routledge
Gautam Dey @gautamdey.bsky.social · 07/04/2025
🌍🔬 📣 Please spread the word! Join us! How can cell biology shape a more resilient planet? Virtual registration is still open for the EMBO Workshop on Cells 4 Climate Resilience → meetings.embo.org/event/25-cli... 🗓️ Deadline: April 11 🎥 Watch the teaser → youtu.be/8eMJ91udHDs @embo.org
meetings.embo.org
Your browser does not support or is disabling JavaScript.
22621
Reposted by Dan Routledge
PLOS Biology @plosbiology.org · 07/04/2025
Can we ever have too much #ecological field #data? This Perspective advocates for proper funding and resources to enable collection of long-term ecological data, which is essential to assess animal behavior and adaptation in the face of anthropogenic change 🧪 ▶️ plos.io/44ir6tZ
plos.io
The end of long-term ecological data?
Can we ever have too much ecological field data? Are data sharing norms and the environmental costs of travel disincentivizing its collection? This Perspective advocates for proper funding and resourc...
0205
Reposted by Dan Routledge
Nonia Pariente @npariente.bsky.social · 31/03/2025
Looking forward to this webinar with @scilifelab.se on navigating open science policies. I will speak about open science practices at scientific journals. There’s still time to sign up - come join us! www.scilifelab.se/event/plos-a...
scilifelab.se
PLOS and SciLifeLab Webinar: Navigating Open Science Policies – Practical Guidance for Researchers on Sharing Data and Software
Open science policies are rapidly evolving, but many researchers find them to be vague and difficult to navigate. These policies often lack clear, actionable guidelines for how researchers can respond...
089
Reposted by Dan Routledge
Nonia Pariente @npariente.bsky.social · 31/03/2025
Find out the ins and outs of Registered Reports at the Responsible Research #FREEwebinar on 30 April Join to learn what a registered report is & how it differs from other publication formats, & the benefits of registered reports for authors & science Find out more & register at: lnkd.in/ed3csppN
Announcement of a webinar about Registered Reports. Free registration at https://lnkd.in/ed3csppN
0810
Reposted by Dan Routledge
PLOS Biology @plosbiology.org · 31/03/2025
The coming decade might see major cuts to US Government #funding for biomedicine. This Perspective highlights how your biosciences #PhD gives you the problem-solving skills to navigate this maelstrom, especially if you maintain flexibility, optimism &enthusiasm for uncharted paths🧪 ▶️ plos.io/3XEKPjt
plos.io
Navigating your US bioscience career into the 2030s
The coming decade might see major cuts to US Government funding for biomedicine and the mainstreaming of pseudoscience. This Perspective highlights how your biosciences PhD gives you the problem-solvi...
02610